[Systemic fibrinolysis with recombinant tissue-type plasminogen activator in subrenal aortic occlusions].
D000328:Adult; D001012:Aorta, Abdominal; D001018:Aortic Diseases / Q000628:therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007083:Iliac Artery; D007511:Ischemia / Q000628:therapy*; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D011994:Recombinant Proteins / Q000008:administration & dosage; D013300:Streptokinase / Q000008:administration & dosage; D013927:Thrombosis / Q000628:therapy*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage
D011994:Recombinant Proteins; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator
Systemische Fibrinolyse mit rt-PA subrenaler Aortaverschlüsse.